These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 372858)

  • 1. [Anti-ammonemic activity of the gamma-ethyl ester of glutamic acid. Controlled clinical study].
    Santagati G; Zibetti G; Forgione F; Spaghi A
    Minerva Med; 1979 Feb; 70(8):595-603. PubMed ID: 372858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical treatment of hyperammoniemia in the elderly. Controlled clinical study].
    Marchina MM; Renzi G; Serofilli S
    Minerva Med; 1979 Mar; 70(11):811-8. PubMed ID: 431837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glutamic acid gamma-ethyl ester in high doses in the treatment of high blood ammonia levels in severe hepatic failure].
    Santagati G; Zibetti G; Grignani A
    Minerva Med; 1978 Apr; 69(20):1367-74. PubMed ID: 566393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 6. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of glutamic acid and blood ammonia to hepatic coma.
    ALEXANDER RW; BERMAN E; BALFOUR DC
    Gastroenterology; 1955 Nov; 29(5):711-8. PubMed ID: 13270805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamic acid in hepatic coma.
    WALSHE JM
    Lancet; 1955 Jun; 268(6877):1235-9. PubMed ID: 14382558
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current views on the therapy of hepatic coma].
    Ziegler K
    Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the possibility of using the hyperammonemia test after exercise for evaluation of the anti-ammonemic effectiveness of drugs].
    Secchi GC; Rezzonico A; Gervasini N; Azzollini F; Cocchi A
    Arch Ital Mal Appar Dig; 1966; 33(6):522-8. PubMed ID: 5997754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].
    Ameri AA
    MMW Fortschr Med; 2010 Jun; 152(22):42-3. PubMed ID: 20590033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
    Fodor O; Popescu S; Grigoraş D; Barbarino F
    Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hepatic coma.
    Spellberg MA
    Am J Gastroenterol; 1969 Feb; 51(2):118-28. PubMed ID: 4887357
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with reduced functional liver mass.
    Lee JH; Kim WH; Cho H; Kwak YS; Kim S; Paik WK
    Biochem Biophys Res Commun; 1998 Jul; 248(2):391-4. PubMed ID: 9675147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
    Uribe M; Farca A; Márquez MA; Garcĭa-Ramos G; Guevara L
    Gastroenterology; 1979 Jun; 76(6):1347-51. PubMed ID: 374177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid in the treatment of hepatic coma and its relationship to blood ammonia levels.
    CHAIKIN NW; KONIGSBERG MS
    Am J Gastroenterol; 1957 Mar; 27(3):266-73; discussion, 273-6. PubMed ID: 13402742
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
    Krüger B; Held C; Kircheis G
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.